124 related articles for article (PubMed ID: 32296027)
1. CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.
Zhang Z; Li J; Ou Y; Yang G; Deng K; Wang Q; Wang Z; Wang W; Zhang Q; Wang H; Sun W; Sun P; Yang S
Signal Transduct Target Ther; 2020 Mar; 5(1):25. PubMed ID: 32296027
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
[TBL] [Abstract][Full Text] [Related]
3. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.
Mu M; Zhang Q; Li J; Zhao C; Li X; Chen Z; Sun X; Yu J
Cell Death Differ; 2023 Nov; 30(11):2393-2407. PubMed ID: 37816999
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3.
Zhou C; Jiang H; Zhang Z; Zhang G; Wang H; Zhang Q; Sun P; Xiang R; Yang S
Oncotarget; 2017 Aug; 8(33):54388-54401. PubMed ID: 28903350
[TBL] [Abstract][Full Text] [Related]
5. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1.
Jiang H; Zhou C; Zhang Z; Wang Q; Wei H; Shi W; Li J; Wang Z; Ou Y; Wang W; Wang H; Zhang Q; Sun W; Sun P; Yang S
Nat Commun; 2020 Oct; 11(1):5129. PubMed ID: 33046710
[TBL] [Abstract][Full Text] [Related]
6. OTUD5 cooperates with TRIM25 in transcriptional regulation and tumor progression via deubiquitination activity.
Li F; Sun Q; Liu K; Zhang L; Lin N; You K; Liu M; Kon N; Tian F; Mao Z; Li T; Tong T; Qin J; Gu W; Li D; Zhao W
Nat Commun; 2020 Aug; 11(1):4184. PubMed ID: 32826889
[TBL] [Abstract][Full Text] [Related]
7. WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC.
Deng K; Liu L; Tan X; Zhang Z; Li J; Ou Y; Wang X; Yang S; Xiang R; Sun P
Signal Transduct Target Ther; 2020 Apr; 5(1):36. PubMed ID: 32296033
[TBL] [Abstract][Full Text] [Related]
8. Correction to: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.
Zhang Z; Li J; Ou Y; Yang G; Deng K; Wang Q; Wang Z; Wang W; Zhang Q; Wang H; Sun W; Sun P; Yang S
Signal Transduct Target Ther; 2020 Jun; 5(1):103. PubMed ID: 34145216
[No Abstract] [Full Text] [Related]
9. Knockdown of ubiquitin‑specific protease 51 attenuates cisplatin resistance in lung cancer through ubiquitination of zinc‑finger E‑box binding homeobox 1.
Zhou F; Du C; Xu D; Lu J; Zhou L; Wu C; Wu B; Huang J
Mol Med Rep; 2020 Aug; 22(2):1382-1390. PubMed ID: 32468048
[TBL] [Abstract][Full Text] [Related]
10. Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer.
Jiang H; Wei H; Wang H; Wang Z; Li J; Ou Y; Xiao X; Wang W; Chang A; Sun W; Zhao L; Yang S
Cell Death Dis; 2022 Mar; 13(3):206. PubMed ID: 35246504
[TBL] [Abstract][Full Text] [Related]
11. CDK4/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1.
Li J; Xiao X; Wang H; Wang W; Ou Y; Wang Z; Jiang H; Liu Y; Zhang Z; Yang S
Cancer Gene Ther; 2022 Aug; 29(8-9):1181-1192. PubMed ID: 35058607
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
13. USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics.
Liu YJ; Zeng SH; Zhang W; Li JP; Yin Y; Zhuang YW; Zhou JY; Liu SL; Zou X
Pharmacol Res; 2023 Feb; 188():106644. PubMed ID: 36603607
[TBL] [Abstract][Full Text] [Related]
14. ZEB1: Catalyst of immune escape during tumor metastasis.
Lu J; Fei F; Wu C; Mei J; Xu J; Lu P
Biomed Pharmacother; 2022 Sep; 153():113490. PubMed ID: 36076506
[TBL] [Abstract][Full Text] [Related]
15. ZEB1: New advances in fibrosis and cancer.
Cheng L; Zhou MY; Gu YJ; Chen L; Wang Y
Mol Cell Biochem; 2021 Apr; 476(4):1643-1650. PubMed ID: 33417164
[TBL] [Abstract][Full Text] [Related]
16. Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs.
Waryah C; Alves E; Mazzieri R; Dolcetti R; Thompson EW; Redfern A; Blancafort P
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370762
[TBL] [Abstract][Full Text] [Related]
17. Post-Translational Modification of ZEB Family Members in Cancer Progression.
Park MK; Lee H; Lee CH
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499447
[TBL] [Abstract][Full Text] [Related]
18. Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis.
Mohammadi Ghahhari N; Sznurkowska MK; Hulo N; Bernasconi L; Aceto N; Picard D
Nat Commun; 2022 Apr; 13(1):2104. PubMed ID: 35440541
[TBL] [Abstract][Full Text] [Related]
19. CDK4/6 inhibitors induce replication stress to cause long-term cell cycle withdrawal.
Crozier L; Foy R; Mouery BL; Whitaker RH; Corno A; Spanos C; Ly T; Gowen Cook J; Saurin AT
EMBO J; 2022 Mar; 41(6):e108599. PubMed ID: 35037284
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
